Responses
Clinical science
Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American Collaborative Retina Study group
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 20 July 2016
- Published on: 20 July 2016Intravitreal bevacizumab for diabetic macular edema: 5-year results of the Pan-American collaborative retina study groupShow More
Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American collaborative retina study group. Dan Calugaru, Mihai Calugaru Department of Ophthalmology, Univ of Medicine Cluj-Napoca/Romania
Re: Intravitreal bevacizamab for diabetic macular oedema: 5-year results of the Pan-American collaborative retina study group. Arevalo et al. Br J Ophthalmol published online on February 24, 2016...
Conflict of Interest:
None declared.